Related Experiment Videos
Promoting excellence in end-of-life care in ALS.
Hiroshi Mitsumoto1, Mark Bromberg, Wendy Johnston
1The Elenor & Lou Gehrig MDA/ALS Research Center, Columbia University Neurological Institute, New York, NY 10032, USA. hm264@columbia.edu
Summary
Improving end-of-life care for Amyotrophic Lateral Sclerosis (ALS) patients requires addressing care variability and decision-making barriers. Further research and policy changes are crucial for optimal patient and caregiver support.
Area of Science:
- Neurology
- Palliative Care
- Health Services Research
Background:
- End-of-life care in Amyotrophic Lateral Sclerosis (ALS) is inconsistent, with undefined initiation times.
- Logistical and financial challenges impede effective end-of-life decision-making for ALS patients.
- A systematic review on end-of-life care issues in ALS was lacking.
Purpose of the Study:
- To enhance end-of-life care for ALS patients and their families using available evidence.
- To stimulate awareness, engagement, and discussion regarding end-of-life care in ALS.
- To pinpoint research gaps and guide future clinical investigations in ALS palliative care.
Main Methods:
- A literature review was conducted by the ALS Peer Workgroup.
- Analysis of the current knowledge landscape regarding ALS end-of-life care.
- Identification of care deficits and formulation of recommendations for standard care and research.
Main Results:
- Gaps exist in integrating interdisciplinary care, including psychosocial and spiritual support.
- Validated instruments for assessing patient and caregiver quality of life are needed.
- Proactive caregiver support programs and public policy changes for improved coverage are recommended.
Conclusions:
- Optimal end-of-life care in ALS necessitates further clinical evidence.
- An interdisciplinary approach, validated quality-of-life assessments, and caregiver support are essential.
- Policy reforms are needed to improve access to medical care, hospice, and caregiver cost coverage.